Ulrike Baum
Biographic Data
| ID | 7920514 |
|---|---|
| NAME | Ulrike Baum |
| GIVEN NAMES | Ulrike |
| FAMILY NAME | Baum |
| SIGNATURE | BAUM U |
| AFFILIATIONS | Otto-von-Guericke-Universität Magdeburg |
| ORCID | 0000-0002-7456-8016 |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2022 |
| LATEST PUBLICATION YEAR | 2023 |
| H-INDEX | 0 |
Brand-specific estimates of influenza vaccine effectiveness for the 2021–2022 season in Europe
Introduction: Development of Robust and Innovative Vaccine Effectiveness (DRIVE) was a European public-private partnership (PPP) that aimed to provide annual, brand-specific estimates of influenza vaccine effectiveness (IVE) for regulatory and public health purposes. DRIVE was launched in 2017 under the umbrella of the Innovative Medicines Initiative (IMI) and conducted IVE studies from its pilot season in 2017-2018 to its final season in 2021-20…
Neurological Outpatients Prefer EEG Home-Monitoring over Inpatient Monitoring—An Analysis Based on the UTAUT Model
Home monitoring examinations offer diagnostic and economic advantages compared to inpatient monitoring. In addition, these technical solutions support the preservation of health care in rural areas in the absence of local care providers. The acceptance of patients is crucial for the implementation of home monitoring concepts. The present research assesses the preference for a health service that is to be introduced, namely an EEG home-monitoring …
No prominent works on this page.
Neurological Outpatients Prefer EEG Home-Monitoring over Inpatient Monitoring—An Analysis Based on the UTAUT Model
Home monitoring examinations offer diagnostic and economic advantages compared to inpatient monitoring. In addition, these technical solutions support the preservation of health care in rural areas in the absence of local care providers. The acceptance of patients is crucial for the implementation of home monitoring concepts. The present research assesses the preference for a health service that is to be introduced, namely an EEG home-monitoring …
Brand-specific estimates of influenza vaccine effectiveness for the 2021–2022 season in Europe
Introduction: Development of Robust and Innovative Vaccine Effectiveness (DRIVE) was a European public-private partnership (PPP) that aimed to provide annual, brand-specific estimates of influenza vaccine effectiveness (IVE) for regulatory and public health purposes. DRIVE was launched in 2017 under the umbrella of the Innovative Medicines Initiative (IMI) and conducted IVE studies from its pilot season in 2017-2018 to its final season in 2021-20…
Medicine (2 works) · AI in Service Interactions (1 work) · Anxiety (1 work) · Applied Psychology (1 work) · Applied Psychology (1 work) · Behavioral Health and Interventions (1 work) · Cohort (1 work) · Confidence interval (1 work) · Demography (1 work) · Electroencephalography (1 work)